Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Infection and Chemotherapy

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jiac.2018.02.011PMID 29555391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptib

  2023cited by this paper
• Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27

  2018cited by this paper
• The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection

  2017influential reference
• Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients

  2017cited by this paper
• The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections

  2017cited by this paper
• Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015.

  2017cited by this paper
• Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.

  2016cited by this paper
• Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction

  2016cited by this paper
• Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

  2016influential reference
• Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.

  2016cited by this paper
• Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene

  2016cited by this paper
• Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010–2011

  2015cited by this paper
• Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options

  2015cited by this paper
• Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013

  2015cited by this paper
• Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.

  2015cited by this paper
• A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections

  2015cited by this paper
• Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013

  2015cited by this paper
• Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.

  2015cited by this paper
• Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

  2015influential reference
• Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?

  2013cited by this paper
• Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections.

  2013cited by this paper
• Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility

  2012cited by this paper
• Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

  2012cited by this paper
• Moxifloxacin monotherapy for treatment of complicated intra‐abdominal infections: a meta‐analysis of randomised controlled trials

  2012cited by this paper
• Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan

  2012influential reference
• Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

  2011cited by this paper
• A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study

  2010cited by this paper
• Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

  2010cited by this paper
• Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).

  2010cited by this paper
• Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis

  2010cited by this paper
• Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

  2010influential reference
• Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study.

  2009cited by this paper
• Choosing Antibiotics for Intra-Abdominal Infections: What Do We Mean by “High Risk”?

  2009cited by this paper
• Cefepime: a reappraisal in an era of increasing antimicrobial resistance

  2008cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases

  2006cited by this paper
• Gene Mutations Responsible for Overexpression of AmpC β-Lactamase in Some Clinical Isolates of Enterobacter cloacae

  2005influential reference
• Characterization of HMRZ-86: a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases.

  2004cited by this paper
• Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.

  2002cited by this paper
• Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

  2001cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper

• Metagenomic Snapshot of Treated Tannery Effluent in Paraguay Reveals Microbiome Diversity and Antibiotic Resistance Genes

  2026cites this paper
• A Retrospective Study Comparing the Effectiveness of Carbapenems and Tazobactam/Piperacillin as an Empirical Treatment for Patients Infected with Bacteroides fragilis.

  2025cites this paper
• Effects of Prospective Audit and Feedback in Patients with Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia

  2024cites this paper
• Breaking resistance: in silico subtractive and comparative genomics approaches for drug targeting in Bacteroides fragilis

  2024cites this paper
• Antibiotic use in surgical infections at a tertiary teaching hospital in Ghana

  2024cites this paper
• Comparison of Mono Therapy with Tazobactam Versus Multi Drug Therapy for Treatment of Perforated Appendix in Children

  2024cites this paper
• Distribution and Antimicrobial Resistance of Complicated Intraabdominal Infection Pathogens in Two Tertiary Hospitals in Egypt

  2024cites this paper
• Results of dynamic monitoring of the spectrum of bacterial causes of acute urinary tract infections in children

  2023cites this paper
• Intra-Abdominal Abscess and Bacteremia Due to Stenotrophomonas maltophilia After Total Gastrectomy: A Case Report and Literature Review

  2023influential citation
• Comparative effectiveness of cefmetazole versus carbapenems and piperacillin/tazobactam as initial therapy for bacteremic acute cholangitis: A retrospective study.

  2023cites this paper
• In vitro efficacy of humanized regimen of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

  2023influential citation
• Intra-abdominal infection after tumor surgery: tigecycline combined with β-lactam antibiotics versus tigecycline alone

  2023cites this paper
• Surgical site wound infection and pain after laparoscopic repeat hepatectomy for recurrent hepatocellular carcinoma

  2023cites this paper
• Correlation between Antimicrobial Resistance and the Hospital-Wide Diverse Use of Broad-Spectrum Antibiotics by the Antimicrobial Stewardship Program in Japan

  2023cites this paper
• Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far

  2022cites this paper
• Pathogen detection in patients with perihilar cholangiocarcinoma: Implications for targeted perioperative antibiotic therapy.

  2022cites this paper
• Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital.

  2022cites this paper
• Laparoscopic liver resection reduces postoperative infection in patients with hepatocellular carcinoma: a propensity score-based analysis

  2022cites this paper
• Outcomes of Beta-Lactam Allergic and Non-Beta-Lactam Allergic Patients with Intra-Abdominal Infection: A Case–Control Study

  2022cites this paper
• The Prevalence and Clinical Significance of Anaerobic Bacteria in Major Liver Resection

  2021cites this paper
• Pharmacokinetics/Pharmacodynamics Evaluation of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli In Vitro and In Vivo in a Murine Thigh Infection Model

  2021cites this paper
• Association of serum and fat tissue antibiotic concentrations with surgical site infections in lower gastrointestinal surgery.

  2021cites this paper
• Comparison of Phenotypic and Genotypic Patterns of Antimicrobial-Resistant Bacteroides fragilis Group Isolated from Healthy Individuals in Vietnam and Japan

  2021cites this paper
• Rapid detection and surveillance of cfiA-positive Bacteroides fragilis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

  2021cites this paper
• Factors Influencing the Prognosis of Patients with Intra-Abdominal Infection and Its Value in Assessing Prognosis

  2021cites this paper
• In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia

  2021cites this paper
• Risk Factors for Acute Cholangitis Caused by Enterococcus faecalis and Enterococcus faecium

  2020cites this paper
• The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia.

  2020cites this paper
• Successful de-escalation antibiotic therapy using cephamycins for sepsis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia: A sequential 25-case series

  2020cites this paper
• Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli

  2019cites this paper
• Evaluation study of using ampicillin susceptibility to predict imipenem susceptibility of E. faecalis and E. faecium

  2019cites this paper
• [New possibilities in antibacterial treatment of intra-abdominal infections caused by multiresistant microflora].

  2019cites this paper
• Improvement of Antibiotics Susceptibility of Escherichia coli in a Tertiary Hospital in Japan

  2019cites this paper
• Comparison between local and national epidemiology of antimicrobial resistance using the JANIS data.

  2018cites this paper